Effect of Evogliptin on Bone Metabolism in Human

NCT02587975 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-07-25

No results posted yet for this study

Summary

This study is designed to measure the effect of evogliptin on bone metabolism in healthy volunteers.

Conditions

Interventions

DRUG

Evogliptin

10 mg

Sponsors & Collaborators

  • DongGuk University

    lead OTHER

Principal Investigators

  • Namyi Gu, MD, PhD · Dongguk University College of Medicine and Ilsan Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-11-30
Completion
2017-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02587975 on ClinicalTrials.gov